ACHE and diabetes mellitus: The EO showed strong inhibitory activity against acetylcholinesterase (IC<sub>50</sub>: 22.9 μg/mL) and α-glucosidase (IC<sub>50</sub>: 14.6 μg/mL), indicating potential for managing neurodegenerative conditions and diabetes, respectively.